Significance of sputum purulence to guide antibiotic therapy in exacerbations of COPD Source: Eur Respir J 2013; 41: 248 Year: 2013
Significance of sputum purulence to guide antibiotic therapy in exacerbations of COPD Source: Eur Respir J 2013; 41: 248-249 Year: 2013
Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD Source: Eur Respir J 2012; 40: 1344-1353 Year: 2012
Changes in patients perception of dyspnoea, sputum volume and sputum purulence during treatment of chronic bronchitis exacerbations Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001
Predictors of exacerbations requiring hospitalisation in patients with stable COPD Source: Eur Respir J 2006; 28: Suppl. 50, 177s Year: 2006
Sputum microbial pattern in severe exacerbations of COPD requiring non-invasive mechanical ventilation Source: Eur Respir J 2004; 24: Suppl. 48, 312s Year: 2004
CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions Source: Eur Respir J, 53 (5) 1802014; 10.1183/13993003.02014-2018 Year: 2019
Is sputum induction a safe procedure during COPD exacerbations? Source: Eur Respir J 2007; 30: Suppl. 51, 183s Year: 2007
Does sputum, biochemical and radiological markers of infection correlate with antibiotic prescribing in acute exacerbations of COPD? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014
Does having previous sputum results improve rationalisation of antimicrobial prescribing during acute exacerbations of COPD? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014
Predicting mortality in patients hospitalised with acute exacerbations of COPD (AECOPD) requiring assisted ventilation Source: Annual Congress 2012 - New scientific findings on noninvasive ventilation in the acute setting Year: 2012
Effect of sputum bacteriology on the prognosis of patients with acute exacerbations of bronchiectasis Source: International Congress 2017 – COPD and weaning Year: 2017
Sputum biomarkers in COPD exacerbations Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011
Microbiological indicators from sputum of patients with exacerbation of COPD Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019 Year: 2019
A comparison of in-hospital and HITH-based treatment of respiratory exacerbations in children with bronchiectasis Source: International Congress 2019 – Novel findings in paediatric respiratory infections Year: 2019
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019 Year: 2019
β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
Validation of Anthonisen criteria in infectious COPD exacerbation among patients requiring hospitalization Source: Eur Respir J 2004; 24: Suppl. 48, 411s Year: 2004
Less is more? Antibiotic treatment duration for exacerbations of bronchiectasis Source: Eur Respir J, 58 (6) 2101416; 10.1183/13993003.01416-2021 Year: 2021